Methods and compositions for improving recombinant protein production

Details for Australian Patent Application No. 2005294373 (hide)

International Classifications

Event Publications

26 April 2007 PCT application entered the National Phase

PCT publication WO2006/041934 Priority application(s): WO2006/041934

20 December 2007 Assignment before Grant

Neuralab Limited; Wyeth The application has been assigned to Wyeth; Elan Pharma International Limited

8 April 2010 Alteration of Name

The name of the applicant has been altered to Elan Pharma International Limited; Wyeth LLC Amendments

10 November 2011 Alteration of Name

The name of the applicant has been altered to Janssen Alzheimer Immunotherapy; Wyeth LLC Amendments 2006

8 December 2011 Application Accepted

Published as AU-B-2005294373

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.